Skip to content
Locust Walk
Menu
About Us
Engaging with Us
Expertise & Due Diligence
Our Team
Leadership
Advisors
Our Capabilities
How We Work
Strategic Transactions
Capital Markets
Strategy Consulting
NewCo Creation
Locust Walk Capital
Our Transactions
Insights
Thought Leadership
Events & Podcasts
Deals and News
Careers
Our Careers
Our Core Values
Our Culture
Our Community Support
Contact Us
CATEGORIES
Asian Capabilities
Capital Raising
Commercial Assessment
ARCHIVE
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
InterMune Divests Actimmune to Vidara Therapeutics
The Locust Walk team is proud to share with you today’s news of our client, InterMune’s, divestiture of Actimmune® (interferon gamma-1b) to Vidara Therapeutics.
RELATED POSTS
Hello world!
Cortendo adds two late‐stage assets and announces $33M financing
Hello world!
Scroll to Top
